Diamonds and Dogs
12/10/14Calithera Biosciences Inc. (CALA)
Calithera Biosciences was painting the tape green today, up 29.88% to $17.17. The biopharmaceutical company saw its shares skyrocket after positive trial news. Calithera announced results of studies with primary human breast tumors that support glutaminase as a potential target in triple negative breast cancer (TNBC). The company's drug, CB-839 was demonstrated in primary TNBC tumor lysates as well as in tumors from a TNBC xenograft model. In addition, glutaminase inhibition of 75-84% was observed in tumor biopsy samples from three solid tumor patients enrolled in early dose cohorts of the ongoing phase I clinical trial. Shares of Calithera climbed nearly $4.00 today to a new 52-week high of $17.94 intraday.
Mitcham Industries Inc. (MIND)
Mitcham Industries is experiencing an earthquake today, getting shook down 20.14% to $5.71. The seismic and geophysical equipment manufacturer saw it shares fall after reporting a worse than expected third quarter. For the quarter, Mitcham management announced a loss of $397.000 or -$0.03 per share, on revenue of $22.9 million. The worse than expected quarter seems to be scaring off investors today, and has added to Mitcham's 60% decline this year. Shares of Mitcham fell nearly $1.50 today to a new 52-week low of $5.71.
Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.